WHO ICTRP trial
Phase I Study of TAS-116 in Patients with Advanced Solid Tumors
JPRN-jRCT2080222394 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2080222394 |
|---|---|
| Public title | Phase I Study of TAS-116 in Patients with Advanced Solid Tumors |
| Scientific title | A Phase I, Dose Escalation Study Evaluating the Safety, Tolerability and Pharmacokinetics of TAS-116 in Patients with Advanced Solid Tumors. |
| Primary sponsor | Taiho Pharmaceutical Co., Ltd. |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 1 |
| Countries | Japan |
| Conditions | Patients with advanced solid tumor |
| Interventions | investigational material(s) Generic name etc : TAS-116 INN of investigational material : - Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : The starting dose of TAS-116 will be… |
| Registration date | Feb 17, 2014 |
| Target size | 150 |
| Secondary IDs | JapicCTI-142444 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: